Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
New England Journal of MedicinePublished 17 June 1993
Philip N. Sambrook, J. Birmingham, Paul Kelly, Susan Kempler, Tuan V. Nguyen, Nicholas Pocock
Citations524
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Calcitriol and calcium, used prophylactically with or without calcitonin, prevent corticosteroid-induced bone loss in the lumbar spine.
Abstract
Calcitriol and calcium, used prophylactically with or without calcitonin, prevent corticosteroid-induced bone loss in the lumbar spine.
Keywords
Medicine
BiometricsSequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
2,302 Citations1975Stuart Pocock, Richard Simon
A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor.
New England Journal of MedicineInvolutional Osteoporosis
1,915 Citations1986B. Lawrence Riggs, L. Joseph Melton
New England Journal of MedicineEffect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
1,089 Citations1990B. Lawrence Riggs, Stephen F. Hodgson +6 more
New England Journal of MedicineIntermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
956 Citations1990Nelson B. Watts, Steven T. Harris +14 more
New England Journal of MedicineSteroid-Induced Fractures and Bone Loss in Patients with Asthma
676 Citations1983Allen Adinoff, J. Roger Hollister
It is concluded that long-term steroid therapy in asthmatic patients is associated with decreased trabecular bone density and an increased prevalence of rib and vertebral fractures.
Proceedings of the National Academy of SciencesContribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.
605 Citations1992N A Morrison, R. Yeoman +2 more
Analysis of the relationship between frequent restriction fragment length polymorphisms (RFLPs, detected by endonucleases Bsm I, EcoRV, and Apa I) that define human vitamin D receptor alleles and serum osteocalcin in a cohort of normal subjects provides a paradigm for the study of functional variation in transacting factors and the role such variation may play in the generation and evolution of physiological diversity.
New England Journal of MedicineTreatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
578 Citations1992Murray Tilyard, G. F. S. Spears +2 more
Journal of Clinical InvestigationDifferential effects of endocrine dysfunction on the axial and the appendicular skeleton.
463 Citations1982Ego Seeman, Heinz W. Wahner +4 more
It is concluded that the effects of endocrine dysfunction on bone density are complex and are both disease and site specific.
Science1,25-Dihydroxyvitamin D-Responsive Element and Glucocorticoid Repression in the Osteocalcin Gene
416 Citations1989Nigel A. Morrison, John Shine +4 more
The active hormonal form of vitamin D3, 1,25-dihydroxyvitamin D3[1,25(OH), which regulates cellular replication and function in many tissues and has a role in bone and calcium homeostasis, acts through a hormone receptor homologous with other steroid and thyroid hormone receptors.
New England Journal of MedicineGlucocorticoid-Induced Osteoporosis
404 Citations1983David J. Baylink
The most disabling of these adverse effects is the development of osteopenia, which is more severe in the regions with high trabecular bone content (spine and ribs), and less striking in predominantly cortical bone areas (Hann et al, 1979).
Bone and MineralBone loss in response to long-term glucocorticoid therapy
378 Citations1990V. LoCascio, E. Bonucci +6 more
The biochemical and histological findings suggest that long-term glucocorticoid therapy causes a reduction of bone turnover, that the bone loss occurs predominantly within the first 6 months of treatment and that patients with lower bone mass have a lower rate of bone loss.
Journal of Clinical InvestigationIntestinal Calcium Absorption in Exogenous Hypercortisonism
361 Citations1977Robert G. Klein, Sara B. Arnaud +3 more
It is suggested that calcium malabsorption in the corticosteroid-treated patients is due to a dose-related abnormality of vitamin D metabolism and not to a direct effect of Corticosteroids on depressing transmucosal intestinal absorption of calcium.
MetabolismImportance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy
358 Citations1983Yasuo Suzuki, Yōichi Ichikawa +2 more
It is concluded that increased urinary calcium excretion plays an important role in the development of secondary hyper parathyroidism in patients under glucocorticoid therapy and that the administration of thiazide and/or vitamin D could improve the secondary hyperparathyroidistan caused by glucocortsolone therapy.
The Journal of Clinical Endocrinology & MetabolismEffects of Short Term Glucocorticoid Administration on Intestinal Calcium Absorption and Circulating Vitamin D Metabolite Concentrations in Man*
309 Citations1981Theodore J. Hahn, Linda R. Halstead +1 more
It is demonstrated that reduced intestinal calcium absorption after glucocorticoid administration cannot be attributed to decreasing circulating concentrations of the major known vitamin D metabolites.
Annals of Internal MedicineCalcitriol Treatment Is Not Effective in Postmenopausal Osteoporosis
308 Citations1989Susan M. Ott, Charles H. Chesnut
Calcitriol is not an effective treatment for established postmenopausal osteoporosis, but renal function was not worse than in the placebo group.
Metabolic Bone Disease and Related ResearchHistomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis
306 Citations1979C Bressot, Pierre J. Meunier +4 more
The results indicate that CS's induce bone rarefaction mainly by decreasing osteoblastic activity at the cell level, however, the bone loss is probably magnified by secondary hyperparathyroidism which increases the birthrate of basic multicellular bone remodelling units.
The Journal of Clinical Endocrinology & MetabolismGenetic Factors in Bone Turnover*
238 Citations1991Paul J. Kelly, John L. Hopper +4 more
The data indicate that circulating osteocalcin, and therefore bone formation, is strongly genetically determined and suggest at least one of the mechanisms of the genetic effect on bone mass relates to the regulation of bone turnover.
Annals of Internal MedicineTreatment of Postmenopausal Osteoporosis with High Doses of Synthetic Calcitriol
219 Citations1990John C. Gallagher, David E. Goldgar
The treatment of postmenopausal osteoporotic women with synthetic calcitriol for 2 years was associated with increases in spine density and total body calcium and no adverse effects on renal function were seen after long-term calcitril therapy.
Journal of Bone and Mineral ResearchCorticosteroid effects on proximal femur bone loss
188 Citations1990Philip Dr. Sambrook, J. Birmingham +6 more
The data suggest that bone loss with corticosteroids is most rapid soon after starting treatment and occurs to a similar extent from the proximal femur to the lumbar spine, and the bone loss at the femoral neck suggests an increased risk of fracture at that site, particularly in older subjects on long‐term Corticosteroid therapy.
The Journal of Clinical Endocrinology & MetabolismLow Serum Osteocalcin Levels in Glucocorticoid-Treated Asthmatics*
187 Citations1986Ian R. Reid, George E. Chapman +6 more
Serum osteocalcin (OC) levels were measured in 19 asthmatic patients receiving long term glucocorticoid therapy and in age- and sex-matched astHmatic patients not receiving this treatment, and multiple regression analysis indicated that OC correlated directly to 1,25-(OH)2D and inversely to glucoc Corticoid dose.
BMJEffect of salcatonin given intranasally on early postmenopausal bone loss.
180 Citations1989Karsten Overgaard, B.J. Riis +2 more
The results suggest that salcatonin given intranasally in the dose used prevents bone loss in the spine of early post menopausal women but does not affect the peripheral skeleton.
Journal of the American Dietetic AssociationA simple method for assessing calcium intake in Caucasian women
168 Citations1989R M Angus, Philip N. Sambrook +2 more
The data show that a short, simple questionnaire can be used to rank individuals according to adequacy of calcium intake as a prerequisite to nutrition intervention.
Clinical EndocrinologyDIAGNOSTIC PROCEDURES IN DISORDERS OF CALCIUM METABOLISM
167 Citations1978B. E. C. Nordin
The investigation of a patient with a suspected disorder of calcium metabolism is most rapidly and efficiently performed by observing a standard procedure.
European Journal of Clinical PharmacologySalmon calcitonin in the therapy of corticoid-induced osteoporosis
155 Citations1987J. D. Ringe, D. Welzel
Evidence of positive effect of calcitonin was derived from the reduced incidence of new fractures occurring during the observation period, and a significant reduction in back pain was a further consequence of the hormone therapy.
Arthritis & RheumatismEffect of oral 1,25‐dihydroxyvitamin D and calcium on glucocorticoid‐induced osteopenia in patients with rheumatic diseases
155 Citations1984T R Dykman, Kathleen Haralson +5 more
It is concluded that 1,25-OH2D should not be used for treatment of glucocorticoid-induced osteopenia and elemental calcium supplementation of 500 mg daily might be useful to maintain skeletal mass in patients receiving long-term glucoc Corticord therapy.
Arthritis & RheumatismSex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis
141 Citations1988P. Sambrook, John A. Eisman +2 more
Prednisolone therapy in 22 patients (mean dosage 8 mg/day) was associated with reductions in estrone and testosterone levels; however, DHEAS and femoral BMD were also decreased in RA patients who were not receiving corticosteroids.
American Journal of Clinical NutritionCalcium supplements in the prevention of steroid-induced osteoporosis
130 Citations1986IR Reid, H.K. Ibbertson
It is concluded that calcium supplementation suppresses bone resorption without detectable suppression of indices of bone formation and is, therefore, likely to result in increased bone mass.
Calcified Tissue InternationalPrevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients
125 Citations1991Lidia Montemurro, Gianfranco Schiraldi +4 more
The action of sCT appeared extremely useful, especially in the first year of steroid therapy when corticosteroid-induced mineral loss was maximal, and sCT nasal spray was better tolerated and as effective as i.m. injections.
The Journal of Clinical Endocrinology & MetabolismAge and Menopause-Related Changes in Indices of Bone Turnover*
119 Citations1989Paul J. Kelly, Nicholas Pocock +2 more
Urinary hydroxyproline/creatinine, but not serum osteocalcin or urinary calcium/Creatinine excretion, was a significant predictor of bone mineral density at the lumbar spine and the femoral neck independent of age, consistent with the hypothesis that age-related bone loss after the menopause occurs in the presence of initially increased but subsequently decreasing bone turnover with maintenance of a relative excess of bone resorption.
American Review of Respiratory DiseaseTreatment of Steroid-induced Osteopenia with Calcitonin in Corticosteroid-dependent Asthma: A One-Year Follow-up Study
108 Citations1990M Luengo, César Picado +4 more
The findings show that calcitonin 100 IU, given three times/wk, is an effective drug in the treatment of steroid-induced osteopenia, however, side effects are frequent and cause a high degree of dropout from therapy, suggesting that further studies should be carried out with lower doses of calcitonIn or by other better tolerated forms of delivery such as in a nasal spray.
Hormone ResearchEvidence for Decreased Tubular Reabsorption of Calcium in Glucocorticoid-Treated Asthmatics
104 Citations2008Ian R. Reid, H.K. Ibbertson
It is concluded that glucocorticoid drugs probably inhibit the tubular reabsorption of calcium and that this is likely to contribute to the development of osteoporosis in patients receiving this treatment.
PubMedEffect of oral calcium and vitamin D on glucocorticoid-induced osteopenia.
83 Citations1988J. W. J. Bijlsma, J. A. Raymakers +5 more
It is suggested that patients who are receiving prednisone should be advised to use supplemental calcium, and a small increase in BMC was noted in both groups, but no differences between preventive calcium and calcium plus Vitamin D became evident.
Journal of Clinical PathologyMeasurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex.
82 Citations1982A. Hodgkinson, Theresa L. Thompson
Feeding experiments with gelatin showed that hydroxyproline is rapidly absorbed and excreted in the urine and that a 12-hour (overnight) fast is sufficient to ensure correct and reproducible fasting OHPr: Cr ratios.
Endocrinology1,25-Dihydroxyvitamin D<sub>3</sub>Modulates Glucocorticoid-Induced Alteration in Serum Bone Gla Protein and Bone Histomorphometry
79 Citations1987Paul S. Jowell, Sol Epstein +3 more
It is demonstrated that high doses of cortisone acetate suppress bone formation and that this is reflected in the low serum BGP values, which may be a marker of glucocorticoid-induced bone disease.
Clinical EndocrinologyINFLUENCE OF 1α‐(OH)D<sub>3</sub> ADMINISTRATION ON BONE AND BONE MINERAL METABOLISM IN PATIENTS ON CHRONIC GLUCOCORTICOID TREATMENT; A DOUBLE BLIND CONTROLLED STUDY
72 Citations1983J.J. Braun, D.H. Birkenhäger-Frenkel +4 more
A double‐blind placebo controlled study of 1α‐hydroxyvita‐min D3 (1α‐(OH)D3) 2 μg daily for 6 months, in 14 patients receiving long‐term glucocorticoid treatment.
The Medical Journal of AustraliaDual‐photon bone densitometry in normal Australian women: a cross‐sectional study
60 Citations1987Nicholas Pocock, Stefan Eberl +5 more
There was a relative stability of lumbar bone mineral density and forearm bone mineral content before the menopause, after which there was an age‐related decline, andBone mineral density at all three sites in the proximal femur showed an age-related decline throughout adult life.
PubMedAssessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.
49 Citations1987Jean‐Yves Reginster, D. Denis +2 more
Assessment of the biological activity of nasal SSCT by comparing the fluctuations of parameters reflecting calcium-phosphorus metabolism after nasal instillation, injection of SSCT and injection of placebo found no changes in serum beta-endorphin, magnesium or erythrocyte magnesium levels after administration of calcitonin by the intranasal route or by injection.
PubMedBone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.
46 Citations1988G Rizzato, G Tosi +4 more
The aim of this work is to evaluate if salmon Calcitonin (sCT) is able to prevent osteopenia in the long-term, and to overcome the differences of Vertebral Cancellous Mineral Content (VCMC) due to age and sex.
PubMedPostmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
43 Citations1992P. N. Sambrook, J. Birmingham +5 more
The data suggest adrenal androgen status may influence bone loss in RA and that, although estrogen therapy can prevent bone loss from the spine, it may not preventBone loss at sites near involved joints.
Journal of Bone and Mineral ResearchAcute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals
43 Citations1991Henning K. Nielsen, Kim Brixen +2 more
It is concluded that 1,25‐(OH)2D3 and prednisone have opposing effects on serum OC.